1. Home
  2. LEGN vs WAY Comparison

LEGN vs WAY Comparison

Compare LEGN & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • WAY
  • Stock Information
  • Founded
  • LEGN 2014
  • WAY 1999
  • Country
  • LEGN United States
  • WAY United States
  • Employees
  • LEGN N/A
  • WAY N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • WAY
  • Sector
  • LEGN Health Care
  • WAY
  • Exchange
  • LEGN Nasdaq
  • WAY Nasdaq
  • Market Cap
  • LEGN 6.7B
  • WAY 6.5B
  • IPO Year
  • LEGN 2020
  • WAY 2024
  • Fundamental
  • Price
  • LEGN $33.11
  • WAY $37.36
  • Analyst Decision
  • LEGN Strong Buy
  • WAY Strong Buy
  • Analyst Count
  • LEGN 12
  • WAY 12
  • Target Price
  • LEGN $73.36
  • WAY $44.67
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • WAY 2.2M
  • Earning Date
  • LEGN 11-11-2025
  • WAY 11-05-2025
  • Dividend Yield
  • LEGN N/A
  • WAY N/A
  • EPS Growth
  • LEGN N/A
  • WAY N/A
  • EPS
  • LEGN N/A
  • WAY 0.48
  • Revenue
  • LEGN $796,838,000.00
  • WAY $1,011,303,000.00
  • Revenue This Year
  • LEGN $70.75
  • WAY $11.18
  • Revenue Next Year
  • LEGN $52.47
  • WAY $10.30
  • P/E Ratio
  • LEGN N/A
  • WAY $77.80
  • Revenue Growth
  • LEGN 74.75
  • WAY 17.14
  • 52 Week Low
  • LEGN $27.34
  • WAY $26.15
  • 52 Week High
  • LEGN $52.31
  • WAY $48.11
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 36.16
  • WAY 49.35
  • Support Level
  • LEGN $33.20
  • WAY $36.94
  • Resistance Level
  • LEGN $34.71
  • WAY $41.47
  • Average True Range (ATR)
  • LEGN 1.22
  • WAY 1.13
  • MACD
  • LEGN -0.09
  • WAY 0.15
  • Stochastic Oscillator
  • LEGN 10.96
  • WAY 28.95

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: